Smoking Termination Opportunity for inPatients

• Status: Completed
• Trial end date: 2011-12-01
• Target enrollment: 0
• Participant gender: All

Summary

The Smoking Termination Opportunity for inPatients, (STOP) project is designed to capture the opportunity that is provided by admission for acute smoking related illness, to assist patients through withdrawal by use of a combination of:

• the new medication Champix with

• best practice counselling

• initiated in an inpatient setting

to achieve:

• sustained smoking abstinence

• reduced hospital bed and health service utilisation

• reduced inpatient smoking and craving prior to discharge

• Phase: Phase 2/Phase 3
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: The Queen Elizabeth Hospital
• Treatments: Varenicline

Criteria

Inclusion Criteria:

• Smoker of at least 10 cigarettes per day on average over the past 12 months

• Inpatient with an anticipation admission of at least one day

• Willingness to quit smoking

• Aged between 20 and 75 years

• A plan of discharge to go home

• Acute hospital admission with cardiovascular, cerebrovascular, peripheral vascular diseases or airways (asthma and/or Chronic Obstructive Pulmonary disease

Exclusion Criteria:

• Subject preference to use an alternative pharmacotherapy for smoking cessation

• Respiratory patient being considered for home oxygen

• Pregnancy

• Breast feeding

• Acute or pre-existing severe psychiatric illnesses

• Past history of psychosis or suicidal ideation

• Renal impairment with creatinine clearance <30ml/min